Is an electronic signature legally acceptable?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and under UETA in adopted states when intent, consent, attribution, and reliable retention are documented. Verify exceptions for documents expressly excluded by statute.

What signer authentication methods should I use?

Choose an authentication level proportional to sensitivity: email verification for low-risk approvals; SMS or two-factor for routine signers; KBA or ID credential checks for higher-risk or regulated records. For HIPAA-covered workflows, combine strong authentication with a BAA.

Do research forms require notarization or remote notarization?

Most Research Developmental Study forms do not require notarization. Certain legal instruments attached to a study may. Over 45 states permit permanent RON; verify specific state notary rules with the state notary commission or NCSL guidance.

How do I amend or correct a signed study document?

Do not alter an executed copy. Create a dated amendment or addendum that all parties sign. Maintain the original signed version, record the amendment in version history, and preserve the audit trail for provenance.

How long must signed records be kept?

Follow federal baselines: maintain financial records for three years (IRC §6501(a)) and HIPAA-covered records for six years (45 CFR §164.530(j)). Adjust for longer state or sponsor-specific retention requirements.

Which supporting documents should accompany submission?

Include final consent forms, budget justification, CVs for key personnel, the data management plan, and any DUAs or vendor agreements. Providing complete attachments avoids administrative holds or IRB clarification requests.

Electronic Signature
Templates
Miscellaneous
Research Developmental Study

Research Developmental Study

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Research Developmental Study Agreement

Agreement Date: Sponsor Name: Researcher/Institution Name:

Recitals

WHEREAS, Sponsor is engaged in the funding and oversight of research projects and desires to fund a developmental research study relating to the topic described in this Agreement; and

WHEREAS, Researcher/Institution possesses the personnel, facilities, and expertise to conduct the Research Developmental Study described herein and agrees to perform the research in accordance with the terms of this Agreement; and

NOW, THEREFORE, in consideration of the mutual covenants set forth below and other good and valuable consideration, the Parties agree as follows:

1. Scope of Work

Study Title Scope of Work Deliverables

Anticipated Start Date: Anticipated End Date:

2. Payment Terms

Sponsor agrees to pay Researcher the total project fee of $ for performance of the Scope of Work set forth herein.

Payment Schedule / Milestones

Invoices shall be submitted to Sponsor in accordance with the schedule above. Payments not received within days of invoice date shall accrue interest at per month (or the maximum permitted by law, if lower).

3. Term and Termination

This Agreement commences on the Effective Date set forth above and shall continue until the completion of the Scope of Work or until , unless earlier terminated as provided herein.

Either Party may terminate this Agreement for convenience upon providing written notice to the other Party not less than days prior to the effective date of termination. Termination for material breach by either Party shall be effective upon written notice if the breaching Party fails to cure within thirty (30) days of receiving notice of breach.

Obligations on Termination

4. Confidentiality

Each Party shall treat as Confidential Information all non-public information disclosed by the other Party in connection with this Agreement, including research data, protocols, analysis, unpublished results, and technical information. Confidential Information shall not include information that (a) is or becomes publicly available through no fault of the receiving Party; (b) was already known to the receiving Party at the time of disclosure as evidenced by written records; or (c) is lawfully obtained by the receiving Party from a third party not subject to confidentiality obligations.

The receiving Party shall use Confidential Information only for the performance of this Agreement, shall take reasonable measures to protect such Confidential Information, and shall not disclose it to any third party except to employees, contractors, or agents with a need to know who are bound by confidentiality obligations no less protective than those in this Agreement. Confidentiality obligations survive termination of this Agreement for years.

5. Intellectual Property

Unless otherwise agreed in writing, background intellectual property remains the property of the originating Party. All Research Data, results, reports, and deliverables generated specifically in performance of this Agreement (collectively, "Foreground IP") shall be owned by . Parties may record additional agreed terms regarding licensing, assignment, or joint ownership in the field below.

Intellectual Property Terms / Licensing

6. Regulatory Compliance and Approvals

Researcher shall perform the Study in compliance with all applicable laws, regulations, and institutional policies. Where applicable, Researcher shall obtain and maintain necessary approvals, including institutional review board or ethics approvals, and shall provide documentation of such approvals to Sponsor upon request.

IRB/Ethics Approval Obtained: (check if obtained)

7. Warranties; Liability

Each Party represents that it has the authority to enter this Agreement. Researcher warrants that services will be performed in a professional manner consistent with prevailing industry standards. EXCEPT FOR THE FOREGOING, NEITHER PARTY MAKES ANY OTHER WARRANTIES, EXPRESS OR IMPLIED. TO THE EXTENT PERMITTED BY LAW, LIABILITY OF EITHER PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL BE LIMITED TO DIRECT DAMAGES NOT TO EXCEED THE AMOUNTS PAID BY SPONSOR UNDER THIS AGREEMENT DURING THE PRIOR TWELVE (12) MONTHS. NEITHER PARTY SHALL BE LIABLE FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES.

8. Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to its conflict of laws principles.

9. Entire Agreement; Amendments

This Agreement, including any exhibits or attachments expressly incorporated herein, constitutes the entire agreement between the Parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, understandings, and communications, whether written or oral. Any amendment or modification of this Agreement must be in writing and signed by authorized representatives of both Parties.

Additional Terms or Special Provisions

Sponsor Printed Name:

By:

Date:

Researcher Printed Name:

By:

Date:

What the Research Developmental Study Is and When It’s Used

The Research Developmental Study is a structured protocol document used to plan, document, and authorize the preparatory phase of a research project. It typically defines objectives, hypotheses, study design, participant criteria, data collection methods, timelines, and required approvals. Institutions use it to secure internal review, funding milestones, and resource allocation before full protocol development. The document supports reproducibility by recording methodology and versioned changes, and often includes appendices for instruments, consent templates, and data management plans. It informs budgets, staffing, and compliance oversight.

Why a Clear Developmental Study Matters for Review and Compliance

Use the Research Developmental Study to document study scope, reduce regulatory risk, and provide an audit-ready record for institutional review boards and sponsors. Clear documentation helps align teams, support funding requests, and demonstrate compliance with policy and oversight requirements.

Who Prepares and Reviews This Document

Principal investigators, research coordinators, and institutional review board staff commonly prepare or review the Research Developmental Study to confirm feasibility and compliance before full protocol submission.

Principal Investigator — defines objectives, oversees study design, and signs approvals.
Research Coordinator — prepares operational details, recruitment plans, and data collection schedules.
IRB/Compliance Officer — reviews ethics, consent language, and regulatory risk mitigation.

Other contributors often include biostatisticians, data managers, sponsors, and grant administrators during review and budgeting.

Core Sections to Include in a Professional Developmental Study

Essential sections in a Research Developmental Study clarify design, data handling, resources, timelines, and approvals to support reproducible and compliant research.

Overview

Summarize aims, primary hypotheses, and high-level rationale. Include measurable objectives, expected outcomes, and how the study advances scientific or programmatic goals. State target population and scope.

Design

Describe study type, control groups, randomization, blinding, sample size justification, and statistical approach. Reference power calculations and inclusion/exclusion criteria with citations to methodology standards and expected variability estimates.

Participants

Define eligibility, recruitment methods, consent procedures, anticipated enrollment timeline, retention strategies, and any vulnerable population safeguards required by IRB and regulatory policy.

Data

Detail data elements, collection instruments, storage location, de-identification plan, access controls, and retention period. Specify formats and metadata standards and data sharing or transfer conditions.

Resources

List personnel, facilities, equipment, software, estimated budget, funding sources, and contingency plans. Include procurement timelines and vendor contacts where relevant.

Approvals

Identify required approvals (IRB, privacy office, data use agreements, conflict-of-interest disclosures) and estimated review timelines, and list sponsor or institutional compliance checkpoints with contact and escalation paths.

Required Administrative and Security Data Fields

Study Title: Official registered title used in all records

PI Name: Full legal name and credentials

Effective Date: MM/DD/YYYY format for start date

IRB Approval: Include IRB ID and approval date

Data Storage: Location, encryption, and access controls

Retention: Retention period and disposal method

Step-by-Step: Complete and Authorize the Developmental Study

Follow these steps to complete and authorize a Research Developmental Study for institutional use and regulatory review.

01

Draft: Assemble aims, methods, and preliminary budget.
02

Review: Circulate to co-investigators and biostatistics for comments.
03

Compliance: Submit consent language and risk assessment to IRB.
04

Finalize: Incorporate feedback, secure approvals, and set version control.

Configure an Online Workflow for Submission and Signatures

Configure an online workflow to collect signatures, attach supporting files, and automate routing for approvals.

Field	Configuration
Preferred signer authentication verification method	Email, SMS code, or ID check
Signature fields and required attachments	Signature, initials, date, and file upload
Conditional routing and workflow triggers	Route based on role, approval, or form values
Audit trail and document retention settings	Enable full audit logs, timestamps, and export

Where the Study Goes After You Finish It

Typical submission flow for the Research Developmental Study from authoring to storage and review and audit.

Upload: Attach study document and supporting appendices.
Assign: Set signers, reviewers, and order.
Sign: Collect signatures with authentication and timestamp.
Archive: Store signed copy with audit trail and metadata.

Technical Requirements for eSubmission and Records

Digital submission requires a platform that supports secure e-signatures, audit trails, and file attachments for IRB and sponsor review.

File formats: PDF, DOCX, and CSV accepted
Integrations: Connect with Google Drive, NetSuite, Box
Authentication: Email, SMS, SSO, and KBA options

Typical Deadlines and Timing Considerations

Key deadlines for drafting, review, and approvals that typically affect Research Developmental Study timelines and sponsor reporting.

Draft completion target:

Set internal deadline two to four weeks before IRB submission

Institutional IRB administrative pre-review window:

Allow 2–6 weeks for administrative review prior to full board

Sponsor internal scientific and administrative review:

Budget and compliance checks may require 1–4 weeks

Final IRB approval and documentation issuance:

Secure approval before participant recruitment; timeline varies by board

Post-approval reporting and amendment timelines:

Submit amendments or safety reports within IRB-specified timelines

Common Mistakes to Avoid When Preparing the Study

Failing to define inclusion and exclusion criteria precisely leads to enrollment delays, IRB questions, and potential bias in sample selection.
Incomplete data management plans that omit de-identification, storage location, or access permissions increase regulatory risk and obstruct data sharing.
Underestimating resource needs or timelines produces budget shortfalls, missed milestones, and repeated amendment cycles that burden administrative staff.
Using vague consent language or failing to provide withdrawal procedures causes IRB revisions and may compromise ethical oversight.

Consequences of Incomplete or Noncompliant Documentation

HIPAA Violations: Civil penalties, corrective action

IRB Noncompliance: Suspension of approval

Funding Risk: Withholding or repayment obligations

Data Loss: Breach costs and reputational harm

Legal Liability: Lawsuits or enforcement actions

Publication Retraction: Invalidated results and citations

Supporting Documents to Include with the Developmental Study

Attach common supporting documents to streamline review and provide context for IRB, sponsor, and institutional reviewers during protocol and budget evaluation.

Consent Form

Final IRB-approved consent templates that match study procedures, include risks, benefits, withdrawal rights, and HIPAA authorization where applicable; use clear version numbering for control.

Budget

Detailed budget showing personnel, equipment, indirect costs, contingency lines, and funder restrictions. Provide cost justifications and any matched or conditional funding commitments.

CVs

Current CVs for PI and key personnel highlighting relevant experience, publications, and prior human subjects research to demonstrate qualifications and oversight capability.

Data Use Agreement

Signed data use agreements or DUAs specifying permitted uses, transfer protections, retention obligations, and responsibilities for secondary use or sharing.

Frequently Asked Questions and Practical Answers

Common questions about completing, submitting, and maintaining a Research Developmental Study, with practical answers for routine issues.

Need help? Contact support

Is an electronic signature legally acceptable?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and under UETA in adopted states when intent, consent, attribution, and reliable retention are documented. Verify exceptions for documents expressly excluded by statute.
What signer authentication methods should I use?
Choose an authentication level proportional to sensitivity: email verification for low-risk approvals; SMS or two-factor for routine signers; KBA or ID credential checks for higher-risk or regulated records. For HIPAA-covered workflows, combine strong authentication with a BAA.
Do research forms require notarization or remote notarization?
Most Research Developmental Study forms do not require notarization. Certain legal instruments attached to a study may. Over 45 states permit permanent RON; verify specific state notary rules with the state notary commission or NCSL guidance.
How do I amend or correct a signed study document?
Do not alter an executed copy. Create a dated amendment or addendum that all parties sign. Maintain the original signed version, record the amendment in version history, and preserve the audit trail for provenance.
How long must signed records be kept?
Follow federal baselines: maintain financial records for three years (IRC §6501(a)) and HIPAA-covered records for six years (45 CFR §164.530(j)). Adjust for longer state or sponsor-specific retention requirements.
Which supporting documents should accompany submission?
Include final consent forms, budget justification, CVs for key personnel, the data management plan, and any DUAs or vendor agreements. Providing complete attachments avoids administrative holds or IRB clarification requests.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now